TradingView
RocketTickers
28 janv. 2019 16:56
ALLO Announces FDA Clearance of the IND for ALLO-501
Long
NASDAQ:ALLO
1D
Allogene Therapeutics, Inc.
NASDAQ
Description
⋅
28 janv. 2019 16:56
ALLO: Allogene Therapeutics, Inc.
2019-01-28 08:30:00
Allogene Therapeutics, in Collaboration with Servier, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR T™) Therapy
Beyond Technical Analysis
Commentaires
BasedDeptGeneral
⋅
27 févr. 2019 09:17
This isn't an idea. You literally just typed some stuff, did no TA, and hit publish.
Plus